Immunoinformatics Design and In Vivo Immunogenicity Evaluation of a Conserved CTL Multi-Epitope Vaccine Targeting HPV16 E5, E6, and E7 Proteins
Vaccines · 09.04.2024 · 12 (4) · 392
DOI: 10.3390/vaccines12040392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 09.04.2024. Verfasst von Ni Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Disease, Institute of Medical Biology, Chinese Academy of Medical Scienc…. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the CAMS Innovation Fund for Medical Sciences, The Yunnan Provincial Science and Technology Department, National Science Foundation of China.
Abstract (Originalsprache)
Human papillomavirus type 16 (HPV16) infection is responsible for more than 50% of global cervical cancer cases. The development of a vaccine based on cytotoxic T-lymphocyte (CTL) epitopes is a promising strategy for eliminating pre-existing HPV infections and treating patients with cervical cancer. In this study, an immunoinformatics approach was used to predict HLA-I-restricted CTL epitopes in HPV16 E5, E6, and E7 proteins, and a set of conserved CTL epitopes co-restricted by human/murine MHCs was screened and characterized, with the set containing three E5, four E6, and four E7 epitopes. Subsequently, the immunogenicity of the epitope combination was assessed in mice, and the anti-tumor effects of the multi-epitope peptide vaccine E5E6E7pep11 and the recombinant protein vaccine CTB-Epi11E567 were evaluated in the TC-1 mouse tumor model. The results demonstrated that mixed epitope peptides could induce antigen-specific IFN-γ secretion in mice. Prophylactic immunization with E5E6E7pep11 and CTB-Epi11E567 was found to provide 100% protection against tumor growth in mice. Moreover, both types of the multi-epitope vaccine significantly inhibited tumor growth and prolonged mouse survival. In conclusion, in this study, a multi-epitope vaccine targeting HPV16 E5, E6, and E7 proteins was successfully designed and evaluated, demonstrating potential immunogenicity and anti-tumor effects and providing a promising strategy for immunotherapy against HPV-associated tumors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Disease, Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650118, China.
- Department of Gynaecologic Oncology, Peking University Cancer Hospital Yunnan & Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China.
- Department of Immunogenetics, Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650118, China.
ORCID-Profile: Yufeng Yao, Li Shi
Förderung
- the CAMS Innovation Fund for Medical Sciences
- The Yunnan Provincial Science and Technology Department
- National Science Foundation of China
- The Association Foundation Program of Yunnan Provincial Science and Technology Department and Kunming Medical University
- CAMS Innovation Fund for Medical Sciences
- Yunnan Provincial Science and Technology Department
- NMPA Key Laboratory for Quality Control and Evaluation of Vaccines and Biological Products
- Yunnan Province Xingdian Talent
Zitieren
APA
Guo, N., Niu, Z., Yan, Z., Liu, W., Shi, L., Li, C., Yao, Y., & Shi, L. (2024). Immunoinformatics Design and In Vivo Immunogenicity Evaluation of a Conserved CTL Multi-Epitope Vaccine Targeting HPV16 E5, E6, and E7 Proteins. Vaccines, 12(4), 392. https://doi.org/10.3390/vaccines12040392
Vancouver
Guo N, Niu Z, Yan Z, Liu W, Shi L, Li C, et al. Immunoinformatics Design and In Vivo Immunogenicity Evaluation of a Conserved CTL Multi-Epitope Vaccine Targeting HPV16 E5, E6, and E7 Proteins. Vaccines. 2024;12(4):392. doi:10.3390/vaccines12040392
BibTeX
@article{Guo2024,
author = {Guo, Ni and Niu, Zhixin and Yan, Zhiling and Liu, Weipeng and Shi, Lei and Li, Chuanyin and Yao, Yufeng and Shi, Li},
title = {Immunoinformatics Design and In Vivo Immunogenicity Evaluation of a Conserved CTL Multi-Epitope Vaccine Targeting HPV16 E5, E6, and E7 Proteins},
journal = {Vaccines},
year = {2024},
volume = {12},
number = {4},
pages = {392},
doi = {10.3390/vaccines12040392}
}
EUVIMED